Broxyquinoline
Chemical compound
- A07AX01 (WHO) G01AC06 (WHO) P01AA01 (WHO)
- 5,7-Dibromoquinolin-8-ol
- 521-74-4
Y
- 2453
- 2359
N
- UK4C618C8T
- ChEMBL223448 N
- DTXSID9045849
- Interactive image
- Brc1c(O)c2ncccc2c(Br)c1
InChI
- InChI=1S/C9H5Br2NO/c10-6-4-7(11)9(13)8-5(6)2-1-3-12-8/h1-4,13HN
- Key:ZDASUJMDVPTNTF-UHFFFAOYSA-NN
N
Y (what is this?) (verify)Broxyquinoline is an antiprotozoal agent.[citation needed]An association with exercise intolerance has been reported.[1]
References
- ^ Swain R, Bapna JS (January 1986). "Impairment of exercise tolerance due to broxyquinoline-brobenzoxaldine combination". Human Toxicology. 5 (1): 63–4. doi:10.1177/096032718600500115. PMID 3081430. S2CID 23922563.
- v
- t
- e
Antidiarrheals, intestinal anti-inflammatory and anti-infective agents (A07)
- Charcoal
- Bismuth (including bismuth subsalicylate, known as Pepto-Bismol)
- Pectin
- Kaolin
- Crospovidone
- Attapulgite
- Diosmectite
- Opium tincture (laudanum)
- Codeine
- Morphine
- Camphorated opium tincture (paregoric)
- crosses BBB: Diphenoxylate (+atropine)
- Difenoxin
- does not cross BBB: Eluxadoline
- Loperamide# (+simethicone)
- corticosteroids acting locally
- antiallergic agents, excluding corticosteroids
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
 | This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
 | This antiinfective drug article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
